Global Post Surgical Gynecologic Infection Treatment Market, By Type (Superficial Incisional Surgical Infection Vaginal Cuffs Cellulitis, Deep Incisional Surgical Infection Includes Pelvic Cellulitis, Organ Surgical Infection Incudes Adnexal Infection and Pelvic Abscesses), Treatment (Antimicrobials, Antibiotics), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Post Surgical Gynecologic Infection Treatment Market Analysis and Size
The global post surgical gynecologic infection treatment market is expected to witness significant growth during the forecast period. The patient who develop post surgical gynecologic infection are most likely to die, or have prolonged exposure in ICU units and are more prone to re-admitting in the hospitals and thus, restraint the post surgical gynecologic infection treatment market. Some of the major benefits of a single-site incision laparoscopic procedure are low chances of infections, quick recovery, better cosmetic results, and less post-operative pain. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global post surgical gynecologic infection treatment market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Post Surgical Gynecologic Infection Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Superficial Incisional Surgical Infection Vaginal Cuffs Cellulitis, Deep Incisional Surgical Infection Includes Pelvic Cellulitis, Organ Surgical Infection Incudes Adnexal Infection and Pelvic Abscesses), Treatment (Antimicrobials, Antibiotics), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), Sanofi S.A.(France), CLOVIS ONCOLOGY (U.S.), Bayer AG (Germany), Lilly (U.S.), Merck & Co., Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AbbVie Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (U.S.), Fresenius Kabi AG (Germany)
|
|
Market Opportunities
|
|
Market Definition
Postoperative infection is the most common site complication of surgical procedures in gynaecology. The Centres for Disease Control and Prevention (CDC) defined an SSI as a type of infection that occurs within 30 days of an operation in one of three locations that are superficial at the incision site, deep at the incision site, or in other organs or spaces opened or manipulated during an operation.
Global Post Surgical Gynecologic Infection Treatment Market Dynamics
Drivers
- Increased Health Insurance Policies
Rising health insurance in the market is expected to boost the market growth. Minimally invasive laparoscopic surgeries are being covered by numerous health insurance providers in selected countries. For instance, Medicare now covers up to 75% of laparoscopic operations, as listed in the Medicare Benefits Schedule (MBS). These factors have led to patients' increased preference for minimally invasive surgeries. This boosts the market growth.
- Rise in Uterine Cancer
Increase in uterine cancer cases boost the growth of the market. Uterine cancer is one of the most prevalent gynecological disorders worldwide and its incidence is rising at an exponential rate. The increase in obesity cases has commonly driven this upsurge. For instance, as per the American Cancer Society, Inc., about, 66,570 new uterine cancer cases are expected to be diagnosed in 2021. Furthermore, the Canadian Cancer Society projected almost 7,400 women in Canada were estimated to be diagnosed with uterine cancer in 2020. This boosts the market growth.
Opportunities
- Growing Healthcare Infrastructure and Policies
The presence of a large patient pool, a strong presence of key players, ease of drug availability, well-established healthcare infrastructure, favorable reimbursement policies in the healthcare system, rise in R&D, and innovation activities and higher adoption of advanced therapeutics may create opportunities for the market.
- Increasing Demand for Retail Pharmacies
The rise in the number of drugs for post surgical infection delivered through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for the market growth. In addition to this, patients choose retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Lack of Skilled Professionals
Lack of trained professionals who are unaware of the treatment methods for this disease could curb the growth of the global post surgical gynecologic infection treatment market over a forecast period.
- High Cost
The huge expenditure associated with the treatment procedures and medications hampers the market growth.
This global post surgical gynecologic infection treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global post surgical gynecologic infection treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Post Surgical Gynecologic Infection Treatment Market Scope
The global post surgical gynecologic infection treatment market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Superficial Incisional Surgical Infection Vaginal Cuffs Cellulitis
- Deep Incisional Surgical Infection Includes Pelvic Cellulitis
- Organ Surgical Infection Incudes Adnexal Infection and Pelvic Abscesses
Treatment
- Antimicrobials
- Antibiotics
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global Post Surgical Gynecologic Infection Treatment Market Regional Analysis/Insights
The global post surgical gynecologic infection treatment market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global post surgical gynecologic infection treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a huge growth for global post surgical gynecologic infection treatment market throughout the forecast period because of the presence of major generic pharmaceuticals companies in this region and rise in government initiatives and special communities.
North America dominates the market due to the increase in the women population as the disease tends to affect to women and large availability of treatment options.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Post Surgical Gynecologic Infection Treatment Market Share Analysis
The global post surgical gynecologic infection treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global post surgical gynecologic infection treatment market.
Key players operating in the global post surgical gynecologic infection treatment market include:
- Johnson & Johnson Private Limited (U.S.)
- Mylan N.V. (U.S.)
- Sun Pharmaceutical Industries Limited (India)
- Sanofi S.A. (France)
- CLOVIS ONCOLOGY (U.S.)
- Bayer AG (Germany)
- Lilly (U.S.)
- Merck & Co., Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- AbbVie Inc. (U.S.)
- Vivesto AB (Sweden)
SKU-